Medtronic MDT Ratios (2014-2026)

NYSE MDT
$92.39 +0.00 (+0.00%)
As of: Sep 9, 2026 · 2:46 PM EDT
Reported Financials

Medtronic Quarterly Ratios

Periods 50 quarters
Latest Jul 2026

Medtronic reported a gross margin of 64.99% and a net margin of 15.17% for the quarter ended Jul 2026. These financial ratios cover 50 quarters of results from Apr 2014 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Profitability
Gross Margin
68.18%68.32%67.97%65.87%66.58%65.20%65.14%65.88%65.42%65.61%64.56%65.12%64.94%66.49%64.75%65.02%65.84%63.83%65.35%64.99%
EBT Margin
19.03%20.47%19.80%14.16%18.39%17.79%18.15%15.53%16.45%18.20%9.95%16.02%18.55%18.57%14.13%15.18%17.82%15.57%18.70%18.13%
EBIT Margin
19.92%21.37%20.66%15.26%18.51%18.01%18.31%16.46%16.78%18.33%12.26%16.15%18.98%19.85%16.09%16.85%18.81%16.24%19.10%18.08%
EBITDA Margin
19.92%21.37%20.66%15.26%18.51%18.01%18.31%16.46%16.78%18.33%12.26%16.15%18.98%19.85%16.09%16.85%18.81%16.24%19.10%18.08%
Operating Margin
19.92%21.37%20.66%15.26%18.51%18.01%18.31%16.46%16.78%18.33%12.26%16.15%18.98%19.85%16.09%16.85%18.81%16.24%19.10%18.08%
Net Margin
16.78%19.10%18.44%12.64%5.75%15.91%13.91%10.33%11.41%16.53%7.66%13.24%15.21%15.71%11.90%12.21%15.42%12.75%12.84%15.17%
FCF Margin
19.09%24.45%20.62%8.91%7.90%16.07%24.37%6.76%2.51%26.31%27.37%5.89%6.59%25.28%23.18%6.81%5.10%25.51%21.26%13.22%
Efficiency
Inventory AverageInventory Avg.
4.32B4.43B4.57B4.71B4.93B5.21B5.33B5.48B5.71B5.74B5.47B5.32B5.45B5.54B5.54B5.68B6.02B6.23B6.13B6.08B
Assets AverageAssets Avg.
91.78B91.78B91.39B90.45B91.58B93.69B92.54B90.86B90.43B90.46B90.41B89.86B89.90B90.01B90.83B91.33B91.16B91.42B92.26B93.17B
Equity AverageEquity Avg.
51.91B52.44B52.72B52.78B52.45B51.84B51.64B51.52B51.51B51.82B51.21B49.29B48.44B49.17B48.94B48.19B48.49B49.03B49.63B50.46B
Invested CapitalInvested Cap.
77.78B77.87B76.84B76.05B78.67B79.75B76.03B76.35B76.73B77.18B75.44B76.03B77.04B76.22B76.77B76.74B77.96B77.27B78.03B79.00B
Asset Utilization RatioAsset Util.
0.350.350.350.340.340.330.340.350.350.360.360.360.370.370.370.370.380.390.390.40
Leverage & Solvency
Interest Coverage RatioInterest Cover
11.4912.1111.696.8611.908.348.378.577.447.895.217.657.639.208.258.219.318.0910.649.48
Debt Ratio
0.280.270.270.260.290.300.270.280.280.280.280.310.310.300.310.310.320.310.300.30
Times Interest Earned
11.4912.1111.696.8611.908.348.378.577.447.895.217.657.639.208.258.219.318.0910.649.48
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
1.551.751.771.030.481.361.310.870.991.460.721.171.421.451.181.151.521.261.391.61
FCF Payout RatioFCF Cover
0.570.450.511.371.510.730.431.764.590.430.391.931.620.430.431.561.990.400.440.71
Dividend YieldDiv. Yield
2.02%2.40%2.44%2.80%3.03%3.23%2.99%3.09%3.95%3.18%3.51%3.61%3.12%3.11%3.33%3.02%3.01%2.80%3.41%3.34%
Payout Ratio
0.690.670.670.660.810.870.960.990.880.860.990.920.840.840.770.770.750.780.750.69
Valuation
Price to EarningsP/E
34.0728.0627.4423.5426.5926.8731.9732.1722.3927.1828.2525.5326.8927.0023.0025.4025.0527.9022.0520.74
Price to SalesP/S
5.074.364.383.963.753.573.883.722.893.563.233.103.523.493.223.483.453.652.932.91
Price to BookP/B
3.092.632.632.332.222.132.342.291.792.212.072.102.382.332.242.482.462.632.132.15
Enterprise Value
150.69B127.41B128.47B114.28B104.23B98.90B113.26B109.73B84.81B106.95B96.77B93.30B108.42B108.04B99.15B111.26B111.96B121.29B98.05B101.13B
EV to EBIT
28.4122.4122.3418.9917.7917.6920.6519.4915.2418.9118.8118.1020.0419.3916.6518.1718.0220.1115.1614.90
EV to EBITDA
28.4122.4122.3418.9917.7917.6920.6519.4915.2418.9118.8118.1020.0419.3916.6518.1718.0220.1115.1614.90
Market Capitalization
161.20B138.46B138.88B122.98B115.48B109.86B121.04B117.42B92.35B115.07B104.57B100.93B116.19B115.74B107.89B119.14B120.08B129.47B106.66B109.33B
Price to FCFP/FCF
27.9224.3923.2321.5023.9526.3726.4326.4222.8323.3420.1119.6221.1321.1720.8122.4723.0723.9319.6617.83
EV to FCF
26.1022.4421.4919.9821.6223.7424.7324.6920.9721.6918.6118.1319.7219.7619.1220.9821.5122.4218.0716.49
EV to CFO
21.0418.1117.4916.0116.5717.5518.7518.8215.2316.5314.2613.5315.0714.8114.0815.5715.7416.6513.3812.59
Return Ratios
Return on Sales [ROS]ROS
19.92%21.37%20.66%15.26%18.51%18.01%18.31%16.46%16.78%18.33%12.26%16.15%18.98%19.85%16.09%16.85%18.81%16.24%19.10%18.08%
Return on Capital Employed [ROCE]ROCE
6.32%6.86%7.28%7.88%7.60%7.05%6.57%6.88%6.89%7.01%6.46%6.48%6.96%7.13%7.64%7.67%7.65%7.36%8.02%8.34%
Return on Invested Capital [ROIC]ROIC
6.32%6.58%6.82%7.18%5.84%5.33%4.97%4.89%5.52%5.62%5.16%5.48%5.93%5.97%6.49%6.61%6.76%6.48%6.57%6.90%
Return on Assets [ROA]ROA
5.15%5.38%5.54%5.78%4.74%4.36%4.09%4.02%4.56%4.68%4.09%4.40%4.81%4.76%5.16%5.14%5.26%5.08%5.24%5.66%
Return on Equity [ROE]ROE
9.11%9.41%9.60%9.90%8.28%7.89%7.33%7.09%8.01%8.17%7.23%8.02%8.92%8.72%9.59%9.73%9.89%9.47%9.75%10.45%